Leave No One Behind: Using a Benefit-Based Advance Market Commitment to Incentivise Development and Global Supply of COVID-19 Vaccines

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-06-30

Type Web Page Author Kalipso Chalkidou Author Hannah Kettler Author Ganesh Ramakrishnan Author Rachel SIlverman Author Adrian Towse URL https://www.cgdev.org/publication/leave-no-one-behind-using-benefit-based-advance-market-commitment-covid-vaccine Date 07/05/2020 Extra Library Catalog: www.cgdev.org Accessed 2020-06-30 19:11:24 Language en Abstract The global effort to control the COVID-19 pandemic has seen an exceptional allocation of public and philanthropic funds to advance the development of diagnostics, therapeutics, and vaccines as quickly as possible. While critical, even these significant commitments represent only a “down payment” on a price tag that could eventually exceed $50 billion just to scale the production of vaccines to control this global pandemic—amounts that cannot be raised through traditional donor and philanthropic commitments. Website Title Center For Global Development Short Title Leave No One Behind